Combination treatment reduces alcohol intake in rats, suggesting new therapy for alcohol use disorder.
These data suggest that brexpiprazole may have the potential to decrease alcohol intake in AUD patients. In addition, brexpiprazole may have a synergistic therapeutic effect with nalmefene in those patients.
No takes yet. Share an insight, caveat, or question.
Amada et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: